Spero Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

02.10.24	Spero Therapeutics Reports Phase 1 Results Show Significant Lung Uptake Of SPR719 (RTTNews)
28.02.24	Spero Announces FDA Clearance Of IND Application For SPR206 (RTTNews)
01.11.23	Spero Therapeutics Appoints Esther Rajavelu CFO (RTTNews)
22.09.22	GSK To Receive Licence From Spero To Develop, Commercialise Tebipenem Pivoxil HBr (RTTNews)
22.09.22	GSK and Spero Therapeutics Announce Exclusive License Agreement for Late-Stage Antibiotic Asset, Tebipenem HBr (GlobeNewswire)
06.09.22	Spero Therapeutics Discusses Resubmission Of NDA For Tebipenem HBr After Discussion With FDA (RTTNews)
20.07.22	SPRO FINAL DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Spero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRO (PR Newswire)
14.07.22	ROSEN, SKILLED INVESTOR COUNSEL, Encourages Spero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRO (PR Newswire)
04.07.22	SPRO INVESTOR NOTICE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Spero Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Ac... (PR Newswire)
28.06.22	ROSEN, LEADING INVESTOR COUNSEL, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPRO (PR Newswire)
21.06.22	SPRO INVESTOR NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPRO (PR Newswire)
11.06.22	ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Spero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRO (PR Newswire)
02.06.22	SPRO INVESTOR NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Spero Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action... (PR Newswire)
27.05.22	Biotech Stocks Facing FDA Decision In June 2022 (RTTNews)
03.05.22	Why Spero Therapeutics Stock Falling In Pre-market? (RTTNews)
01.04.22	TRVN To Report Data In Mid-year, TSHA Trims Workforce, FDA Decision On SPRO's NDA To Be Delayed? (RTTNews)
04.01.22	Spero Therapeutics Says FDA Lifts Clinical Trial Hold On SPR720 - Quick Facts (RTTNews)
03.01.22	Spero's New Drug Application For Tebipenem HBr Tablets Granted Priority Review (RTTNews)
05.07.21	Everest Medicines: Spero Therapeutics, Pfizer In Deal For SPR206 In Ex-U.S. And Ex-Asia Territories (RTTNews)
05.07.21	Everest Medicines Announces that Spero Therapeutics Entered into Licensing Agreement with Pfizer Inc. for SPR206 in ex-U.S. and ex-Asia Territories (PR Newswire)
01.07.21	Spero Therapeutics Adds 14% Following $40 Mln Investment By Pfizer (RTTNews)
23.12.20	CYCC Gets $7Mln Strategic Investment, SUPN Abuzz, SNGX Plunges On Oral Mucositis Trial Data (RTTNews)
29.09.20	Stock Alert: Spero Therapeutics Shares Up 17% (RTTNews)
09.09.20	AZN Pauses COVID-19 Vaccine Trial, ALBO Hits New High, CRBP Plunges, PFE To Invest In TRIL (RTTNews)
08.09.20	Stock Alert: Spero Therapeutics Jumps 15% (RTTNews)
17.10.18	CRMD On Watch, SPRO On Track To Initiate Phase 3 Trial, BMRA's Sales Drop (RTTNews)
02.09.18	10 Pharma Stocks To Watch This Month (RTTNews)
10.08.18	SPRO To Report Data In Q3, ITRM Takes Steady And SURE Steps, PBYI On Watch (RTTNews)
17.07.18	EOLS Slumps On Stock Offering, BLCM CFO To Exit, NVRO Trims Revenue Outlook (RTTNews)
10.07.18	ISR Soars On FDA Nod For GammaTile, KMPH On Watch, Investors Believe In XLRN (RTTNews)
20.06.18	CLBS Firing On All Cylinders, SLDB Gets Ignited, SRPT Walks The Talk, SRRK Rocks (RTTNews)
06.06.18	Antimicrobials Working Group Highlights Member Company Participation at ASM Microbe 2018 (PR Newswire)
11.05.18	BLFS Q1 Revenue Up 61%, VRAY Garners Attention, AKCA Gets FDA Panel Nod (RTTNews)
20.04.18	Antimicrobials Working Group Highlights Member Company Participation at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) (PR Newswire)
29.01.18	Motif Bio PLC, Spero Therapeutics, Inc. and Vical Incorporated Join Antimicrobials Working Group (PR Newswire)
06.12.17	FLKS Shrinks, SCPH Awaits FDA Decision In June, CLSD Looking Ahead To PEACHTREE (RTTNews)
01.12.17	BEAT Upbeat, SYRS Gearing Up For ASH, Catalyst-Rich Year Ahead For ARGX (RTTNews)
21.11.17	SMMT To Report Data In Q1, PRTA Slumps, DBVT's Viaskin Value Realised (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Spero Therapeutics Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten